TCL Archive Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response November 29, 2013
TCL Archive In odd aftermath of FDA Commissioner Mark McClellan’s lecture, NCI Director Andrew von Eschenbach forwards the commissioner’s thank-you note to 3,000 NCI staff. The email blast follows FDA’s return of NCI’s gift to McClellan. March 12, 2004
